Latest filing published 27 Apr 2026 for Iqvia Holdings INC..
No signal scores available.
Filings by Colleen A. Goggins span 3 companies, the busiest being Johnson & Johnson, Iqvia Holdings Inc. and Valeant Pharmaceuticals International, Inc. We count 67 filings; the first trade dates from 30 December 2005 and the latest from 23 April 2026.
The open-market record consists of 7 sales worth €6.1M, with no purchase. Outside the open market, there are 24 share grants and 14 option exercises.
Most recently, on 27 April 2026, the filings show a share grant in Iqvia Holdings Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 67 declarations